190 related articles for article (PubMed ID: 30790396)
1. Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE).
Paitazoglou C; Bergmann MW; Vrtovec B; Chamuleau SAJ; van Klarenbosch B; Wojakowski W; Michalewska-Włudarczyk A; Gyöngyösi M; Ekblond A; Haack-Sørensen M; Jaquet K; Vrangbaek K; Kastrup J;
Eur J Heart Fail; 2019 Aug; 21(8):1032-1041. PubMed ID: 30790396
[TBL] [Abstract][Full Text] [Related]
2. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
Qayyum AA; Mouridsen M; Nilsson B; Gustafsson I; Schou M; Nielsen OW; Hove JD; Mathiasen AB; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Haack-Sørensen M; Ekblond A; Kastrup J
ESC Heart Fail; 2023 Apr; 10(2):1170-1183. PubMed ID: 36638837
[TBL] [Abstract][Full Text] [Related]
3. Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.
Qayyum AA; van Klarenbosch B; Frljak S; Cerar A; Poglajen G; Traxler-Weidenauer D; Nadrowski P; Paitazoglou C; Vrtovec B; Bergmann MW; Chamuleau SAJ; Wojakowski W; Gyöngyösi M; Kraaijeveld A; Hansen KS; Vrangbaek K; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Mathiasen AB; Ekblond A; Haack-Sørensen M; Kastrup J;
Eur J Heart Fail; 2023 Apr; 25(4):576-587. PubMed ID: 36644821
[TBL] [Abstract][Full Text] [Related]
4. Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.
Kastrup J; Haack-Sørensen M; Juhl M; Harary Søndergaard R; Follin B; Drozd Lund L; Mønsted Johansen E; Ali Qayyum A; Bruun Mathiasen A; Jørgensen E; Helqvist S; Jørgen Elberg J; Bruunsgaard H; Ekblond A
Stem Cells Transl Med; 2017 Nov; 6(11):1963-1971. PubMed ID: 28880460
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
6. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.
Kastrup J; Schou M; Gustafsson I; Nielsen OW; Møgelvang R; Kofoed KF; Kragelund C; Hove JD; Fabricius-Bjerre A; Heitman M; Haack-Sørensen M; Lund LD; Johansen EM; Qayyum AA; Mathiasen AB; Ekblond A
Stem Cells Int; 2017; 2017():8506370. PubMed ID: 29056973
[TBL] [Abstract][Full Text] [Related]
7. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial.
Mathiasen AB; Qayyum AA; Jørgensen E; Helqvist S; Kofoed KF; Haack-Sørensen M; Ekblond A; Kastrup J
Eur J Heart Fail; 2020 May; 22(5):884-892. PubMed ID: 31863561
[TBL] [Abstract][Full Text] [Related]
9. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.
Patel AN; Henry TD; Quyyumi AA; Schaer GL; Anderson RD; Toma C; East C; Remmers AE; Goodrich J; Desai AS; Recker D; DeMaria A;
Lancet; 2016 Jun; 387(10036):2412-21. PubMed ID: 27059887
[TBL] [Abstract][Full Text] [Related]
10. The ixCELL-DCM Trial: Rationale and Design.
Henry TD; Schaer GL; DeMaria A; Recker D; Remmers AE; Goodrich J; Patel AN
Cell Transplant; 2016; 25(9):1689-1699. PubMed ID: 27009022
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).
Mathiasen AB; Qayyum AA; Jørgensen E; Helqvist S; Fischer-Nielsen A; Kofoed KF; Haack-Sørensen M; Ekblond A; Kastrup J
Eur Heart J; 2015 Jul; 36(27):1744-53. PubMed ID: 25926562
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.
Makkar RR; Kereiakes DJ; Aguirre F; Kowalchuk G; Chakravarty T; Malliaras K; Francis GS; Povsic TJ; Schatz R; Traverse JH; Pogoda JM; Smith RR; Marbán L; Ascheim DD; Ostovaneh MR; Lima JAC; DeMaria A; Marbán E; Henry TD
Eur Heart J; 2020 Sep; 41(36):3451-3458. PubMed ID: 32749459
[TBL] [Abstract][Full Text] [Related]
15. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
[TBL] [Abstract][Full Text] [Related]
17. Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.
Bolli R; Hare JM; Henry TD; Lenneman CG; March KL; Miller K; Pepine CJ; Perin EC; Traverse JH; Willerson JT; Yang PC; Gee AP; Lima JA; Moyé L; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Ebert RF; Simari RD;
Am Heart J; 2018 Jul; 201():54-62. PubMed ID: 29910056
[TBL] [Abstract][Full Text] [Related]
18. A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Bolli R; Mitrani RD; Hare JM; Pepine CJ; Perin EC; Willerson JT; Traverse JH; Henry TD; Yang PC; Murphy MP; March KL; Schulman IH; Ikram S; Lee DP; O'Brien C; Lima JA; Ostovaneh MR; Ambale-Venkatesh B; Lewis G; Khan A; Bacallao K; Valasaki K; Longsomboon B; Gee AP; Richman S; Taylor DA; Lai D; Sayre SL; Bettencourt J; Vojvodic RW; Cohen ML; Simpson L; Aguilar D; Loghin C; Moyé L; Ebert RF; Davis BR; Simari RD;
Eur J Heart Fail; 2021 Apr; 23(4):661-674. PubMed ID: 33811444
[TBL] [Abstract][Full Text] [Related]
19. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.
Teerlink JR; Metra M; Filippatos GS; Davison BA; Bartunek J; Terzic A; Gersh BJ; Povsic TJ; Henry TD; Alexandre B; Homsy C; Edwards C; Seron A; Wijns W; Cotter G;
Eur J Heart Fail; 2017 Nov; 19(11):1520-1529. PubMed ID: 28560782
[TBL] [Abstract][Full Text] [Related]
20. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
